Completed PHASE1 INTERVENTIONAL 1-arm NCT01437800

BIOAVAILABILITY OF GLI/METXR (4/850 mg) (GLMT12-SIL)

Bioavailability of Glimepiride/Extended Release Metformin (4/850 mg) in Healthy Mexican Volunteers

Sponsor: Instituto Mexicano del Seguro Social

Conditions Healthy

Interventions Glimepiride / Extended release Metformin (4/850 mg).

Updated 6 times since 2017 Last updated: May 3, 2021 Started: Jan 31, 2011 Primary completion: Jan 31, 2011 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01437800, this PHASE1 trial focuses on Healthy and remains completed. Sponsored by Instituto Mexicano del Seguro Social, it has been updated 6 times since 2011, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jun 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Jun 2021 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto Mexicano del Seguro Social
Laboratorios Silanes S.A. de C.V.

Data source: Laboratorios Silanes S.A. de C.V.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• México, Mexico